Sarah Premji, MD

In the blink of an eye - fellowship is over! Grateful to @MayoCancerCare for 3 transformative years of excellent training and mentorship! Beyond excited to join a group I deeply admire at @SCRIOncology who has already warmly welcomed me! @mpgoetz @jonaspaludo @ErikaHamilton9

Check out our ESMO 2025 takeaways! ⁦@ErikaHamilton9⁩ docwirenews.com/post/key-updat…

Celcuity Announces Clinically Meaningful Improvement in Both Progression-Free Survival Primary Endpoints from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Trial Webcast: edge.media-server.com/mmc/p/uu6k4f9k/ PR: ir.celcuity.com/press-releases/ #teamcelcuity #oncology #biotechnology #data #phase3

Proud to share my interview in @AMJ_Oncology reflecting on #ASCO25, the future of ADCs, and how we’re turning knowledge into action for patients. emjreviews.com/en-us/amj/onco… Thanks to @SarahCannonDocs @SCRIOncology for the support and collaboration. #BreastCancer #ClinicalTrials

Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: brnw.ch/21wUiVu

Check out our review of neoadjuvant therapies in triple negative breast cancer and what we believe could be the future, published in @AMJ_Reviews with @rleonferre! emjreviews.com/en-us/amj/onco…

ICYMI: Dr. Robert A. Figlin, @OncNewsCentral's Peer-Spectives podcast host, spoke to our CEO @CliffordHudis about challenges academic oncologists face, including burnout & unrealistic job expectations & how to better support them. Listen Now: brnw.ch/21wU8Jl

Excited to share our review of side effects of novel and emerging #breastcancer therapies in the @ASCO Educational Book. Very grateful for the opportunity to contribute to this work! @hoperugo @npasricha @jleventhal @sdent_cardioonc @OncoAlert #bcsm #ASCO25 💊📚 Read here:…

Dr. Roxana Dronca, a medical oncologist, colleague, and longtime friend, has created a lasting legacy for her daughter Maya through her visionary cancer care work at Mayo and through the Maya Dronca Foundation. Read more: mayocl.in/3IebhM6

Grateful to @ASCO for the opportunity to contribute to #ASCODailyNews with super @Lucarecco discussing how to choose between #abemaciclib or #ribociclib as adjuvant CDK4/6 Inhibitor in ER+/HER2- stage III early #BreastCancer dailynews.ascopubs.org/do/abemaciclib… @OncoAlert @UniGenova #bcsm

⏳Last chance to join us at The Country Music Hall of Fame for the Women’s Health #OncLiveSOSS. Hear directly from @ErikaHamilton9 & @DrKatyMoore on the latest in treatment strategies. 🔗 Secure your spot before it’s gone: hubs.li/Q03r4Myj0 @SarahCannonDocs

Had a chance to speak with CancerNetwork alongside @lungoncdoc, @MinhTriMD, @nerealiamd and @docbraunstein about one of the most underdiscussed—and overwhelming—periods in our careers: preparing for the boards while transitioning from fellowship to faculty. The facts: 📚…

Celebrating our brilliant grant & award recipients at #ASCO25! 🤝 It was inspiring to see them network & connect. View & download photos from the full gallery: brnw.ch/21wTCQc #ConquerCancer #CancerResearch

🚨 Limited seats, legendary location—join us at the Country Music Hall of Fame July 14! Join @ErikaHamilton9 and @DrKatyMoore at the OncLive® Women’s Health State of the Science Summit in Nashville, TN. Register now ➡️ hubs.li/Q03sffb70 @SarahCannonDocs

Appreciate my co-fellows, @AshleyHickmanMD, @jennifer_gile and I we call ourselves “tumor board” and they often leave gifts on my desk for milestones, but this has to be my favorite! Will miss them dearly! @MayoHemeOnc

Stoked to be working with this incredible group! @ASCOTECAG

Thank you, #ASCO25! We’re grateful to our presenters, panelists, and the entire ASCO community for an inspiring week of innovation and collaboration. Here’s to advancing therapies for patients —together. Until next year! #SCRI #CancerResearch #OncologyLeadership #ThankYouASCO

#ASCO2025 was filled with groundbreaking science. Feeling inspired and grateful to be part of this community. These are just a few of the top breast cancer studies presented, and some of the remaining questions.

Three key practice changing trials at #ASCO25, one for each subtype of breast cancer. Things are moving FAST!!!

Small glimpse of *part* of my tribe- a couple of the @SarahCannonDocs crew that so amazingly supports us in every way. My EA Lisa, our #bcsm program manager Mythili, our President and my mentor @BurrisSkip, and of course our CEO @Dee_Anna_Smith (and soon to be @SPremji7866).